Logo image of U-U.CA

SPROTT PHYSICAL URANIUM TR (U-U.CA) Stock Fundamental Analysis

TSX:U-U - Toronto Stock Exchange - CA85210A1049 - Currency: USD

16.46  +0.33 (+2.05%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to U-U. U-U was compared to 83 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making U-U a very profitable company, without any liquidiy or solvency issues. U-U is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year U-U was profitable.
U-U had a negative operating cash flow in the past year.
U-U had positive earnings in 4 of the past 5 years.
In the past 5 years U-U always reported negative operating cash flow.
U-U.CA Yearly Net Income VS EBIT VS OCF VS FCFU-U.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B 2.5B

1.2 Ratios

With an excellent Return On Assets value of 45.42%, U-U belongs to the best of the industry, outperforming 98.65% of the companies in the same industry.
U-U has a Return On Equity of 45.57%. This is amongst the best in the industry. U-U outperforms 97.30% of its industry peers.
The Return On Invested Capital of U-U (32.81%) is better than 97.30% of its industry peers.
U-U had an Average Return On Invested Capital over the past 3 years of 13.96%. This is above the industry average of 9.07%.
The last Return On Invested Capital (32.81%) for U-U is above the 3 year average (13.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 45.42%
ROE 45.57%
ROIC 32.81%
ROA(3y)19.31%
ROA(5y)14.82%
ROE(3y)19.38%
ROE(5y)14.86%
ROIC(3y)13.96%
ROIC(5y)N/A
U-U.CA Yearly ROA, ROE, ROICU-U.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

1.3 Margins

U-U's Profit Margin of 98.90% is amongst the best of the industry. U-U outperforms 94.59% of its industry peers.
In the last couple of years the Profit Margin of U-U has declined.
U-U's Operating Margin of 98.90% is amongst the best of the industry. U-U outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of U-U has declined.
U-U has a better Gross Margin (99.91%) than 98.65% of its industry peers.
In the last couple of years the Gross Margin of U-U has remained more or less at the same level.
Industry RankSector Rank
OM 98.9%
PM (TTM) 98.9%
GM 99.91%
OM growth 3Y-4.06%
OM growth 5Y-3.07%
PM growth 3Y-3.98%
PM growth 5Y-2.54%
GM growth 3Y-1.44%
GM growth 5Y-1.08%
U-U.CA Yearly Profit, Operating, Gross MarginsU-U.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 20 40 60 80 100

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for U-U has been increased compared to 1 year ago.
U-U has more shares outstanding than it did 5 years ago.
U-U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
U-U.CA Yearly Shares OutstandingU-U.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
U-U.CA Yearly Total Debt VS Total AssetsU-U.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

U-U has an Altman-Z score of 99.30. This indicates that U-U is financially healthy and has little risk of bankruptcy at the moment.
U-U's Altman-Z score of 99.30 is amongst the best of the industry. U-U outperforms 95.95% of its industry peers.
U-U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 99.3
ROIC/WACCN/A
WACCN/A
U-U.CA Yearly LT Debt VS Equity VS FCFU-U.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

2.3 Liquidity

U-U has a Current Ratio of 2.03. This indicates that U-U is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of U-U (2.03) is better than 74.32% of its industry peers.
U-U has a Quick Ratio of 2.03. This indicates that U-U is financially healthy and has no problem in meeting its short term obligations.
U-U has a better Quick ratio (2.03) than 74.32% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03
U-U.CA Yearly Current Assets VS Current LiabilitesU-U.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

U-U shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1153.88%, which is quite impressive.
U-U shows a strong growth in Revenue. In the last year, the Revenue has grown by 1140.80%.
EPS 1Y (TTM)1153.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1601.29%
Revenue 1Y (TTM)1140.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1880.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
U-U.CA Yearly Revenue VS EstimatesU-U.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B
U-U.CA Yearly EPS VS EstimatesU-U.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 -0.5 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.08 indicates a rather cheap valuation of U-U.
Compared to the rest of the industry, the Price/Earnings ratio of U-U indicates a rather cheap valuation: U-U is cheaper than 100.00% of the companies listed in the same industry.
U-U's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.47.
Industry RankSector Rank
PE 1.08
Fwd PE N/A
U-U.CA Price Earnings VS Forward Price EarningsU-U.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U-U.CA Per share dataU-U.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of U-U may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

U-U does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPROTT PHYSICAL URANIUM TR

TSX:U-U (2/4/2025, 7:00:00 PM)

16.46

+0.33 (+2.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-16 2024-08-16
Earnings (Next)N/A N/A
Inst Owners18.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.44B
Analysts82.5
Price Target27.16 (65.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.7%
PT rev (3m)-3.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.08
Fwd PE N/A
P/S 1.16
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)15.22
EY92.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS14.2
BVpS30.83
TBVpS30.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 45.42%
ROE 45.57%
ROCE 45.57%
ROIC 32.81%
ROICexc 33%
ROICexgc 33%
OM 98.9%
PM (TTM) 98.9%
GM 99.91%
FCFM N/A
ROA(3y)19.31%
ROA(5y)14.82%
ROE(3y)19.38%
ROE(5y)14.86%
ROIC(3y)13.96%
ROIC(5y)N/A
ROICexc(3y)15.83%
ROICexc(5y)N/A
ROICexgc(3y)15.86%
ROICexgc(5y)N/A
ROCE(3y)19.39%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.06%
OM growth 5Y-3.07%
PM growth 3Y-3.98%
PM growth 5Y-2.54%
GM growth 3Y-1.44%
GM growth 5Y-1.08%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z 99.3
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1153.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1601.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1140.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1880.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1316.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y91.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.93%
OCF growth 3YN/A
OCF growth 5YN/A